The Influence of Medical Comorbidities on Survival Disparities in a Multiethnic Group of Patients with De Novo Metastatic Breast Cancer.

Lauren P Wallner Lie Hong Chen Tiffany A Hogan Farah M Brasfield Reina Haque

Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2022)

Optimizing the management of medical comorbidities in metastatic breast cancer patients may also help reduce disparities in breast cancer-related mortality.

Keyphrases

metastatic breast cancer
healthcare
squamous cell carcinoma
small cell lung cancer
affordable care act
cardiovascular events
risk factors
cardiovascular disease
coronary artery disease
type diabetes
health insurance